Literature DB >> 7564910

Highly-sensitive identification of alpha-fetoprotein mRNA in circulating peripheral blood of hepatocellular carcinoma patients.

N Funaki1, J Tanaka, S Seto, T Kasamatsu, T Kaido, M Imamura.   

Abstract

In order to capture hepatocellular carcinoma (HCC) cells in circulating peripheral blood, we made analysis to see if alpha-fetoprotein (AFP) mRNA exists in the peripheral blood obtained from patients with HCC and also, as a control, from hepatitis-viral-marker-positive patients without HCC and a healthy volunteer. As the number of HCC cells in peripheral blood and the quantity of AFP mRNA are expected to be very small, the analysis was performed by the reverse transcription followed by an original three-step polymerase chain reaction. By this highly-sensitive method, 5 of 7 HCC patients were positive for AFP mRNA. These 5 positive patients consisted of three with clinically apparent recurrence, one preoperative patient with tumor thrombus in the portal vein and one recurrence-free patient who developed clinically detectable recurrence three months after this analysis. Neither 4 patients with positive viral markers nor a healthy volunteer was positive. The results suggest that detection of AFP mRNA from HCC patients' peripheral blood by our highly-sensitive RT-PCR may be a practical and powerful tool to diagnose the preoperative spreading of HCC and to monitor its recurrence.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7564910     DOI: 10.1016/0024-3205(95)02138-9

Source DB:  PubMed          Journal:  Life Sci        ISSN: 0024-3205            Impact factor:   5.037


  3 in total

1.  Alpha-fetoprotein and human telomerase reverse transcriptase mRNA levels in peripheral blood of patients with hepatocellular carcinoma.

Authors:  Sun-Young Kong; Joong-Won Park; Jin Oak Kim; Nam Oak Lee; Jung An Lee; Kyung Woo Park; Eun Kyung Hong; Chang-Min Kim
Journal:  J Cancer Res Clin Oncol       Date:  2009-01-31       Impact factor: 4.553

2.  Cytokeratin 20 mRNA in peripheral venous blood of colorectal carcinoma patients.

Authors:  N O Funaki; J Tanaka; G Ohshio; H Onodera; S Maetani; M Imamura
Journal:  Br J Cancer       Date:  1998-04       Impact factor: 7.640

Review 3.  Clinical applications of liquid biopsy as prognostic and predictive biomarkers in hepatocellular carcinoma: circulating tumor cells and circulating tumor DNA.

Authors:  Jie Li; Xu Han; Xiaona Yu; Zongzhen Xu; Guangsheng Yang; Bingqi Liu; Peng Xiu
Journal:  J Exp Clin Cancer Res       Date:  2018-09-03
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.